FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 336:973-979 April 3, 1997 Number 14 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Inflammation may be important in the pathogenesis of atherothrombosis. We studied whether inflammation increases the risk of a first thrombotic event and whether treatment with aspirin decreases the risk.

Methods We measured plasma C-reactive protein, a marker for systemic inflammation, in 543 apparently healthy men participating in the Physicians' Health Study in whom myocardial infarction, stroke, or venous thrombosis subsequently developed, and in 543 study participants who did not report vascular disease during a follow-up period exceeding eight years. Subjects were randomly assigned to receive aspirin or placebo at the beginning of the trial.

Results Base-line plasma C-reactive protein concentrations were higher among men who went on to have myocardial infarction (1.51 vs. 1.13 mg per liter, P<0.001) or ischemic stroke (1.38 vs. 1.13 mg per liter, P = 0.02), but not venous thrombosis (1.26 vs. 1.13 mg per liter, P = 0.34), than among men without vascular events. The men in the quartile with the highest C-reactive protein values had three times the risk of myocardial infarction (relative risk, 2.9; P<0.001) and two times the risk of ischemic stroke (relative risk, 1.9; P = 0.02) of the men in the lowest quartile. Risks were stable over long periods, were not modified by smoking, and were independent of other lipid-related and non–lipid-related risk factors. The use of aspirin was associated with significant reductions in the risk of myocardial infarction (55.7 percent reduction, P = 0.02) among men in the highest quartile but with only small, nonsignificant reductions among those in the lowest quartile (13.9 percent, P = 0.77).

Conclusions The base-line plasma concentration of C-reactive protein predicts the risk of future myocardial infarction and stroke. Moreover, the reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.

Source Information

From the Divisions of Preventive Medicine (P.M.R., C.H.H.) and Cardiovascular Disease (P.M.R.) and the Channing Laboratory (M.J.S.), Department of Medicine, Brigham and Women's Hospital; the Department of Ambulatory Care and Prevention, Harvard Medical School (C.H.H.); and the Departments of Epidemiology (M.J.S., C.H.H.) and Nutrition (M.J.S.), Harvard School of Public Health — all in Boston; and the Laboratory for Clinical Biochemistry Research, University of Vermont, Burlington (M.C., R.P.T.).

Address reprint requests to Dr. Ridker at the Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave. E., Boston, MA 02215-1204.

Full Text of this Article

Related Letters:

Inflammation, Aspirin, and the Risk of Cardiovascular Disease
Murray W. M., Bruno J. J., Cahill M. R., Perry I. J., Rus H., Niculescu F. I., Ridker P. M., Hennekens C. H., Maseri A.
Extract | Full Text  
N Engl J Med 1997; 337:422-424, Aug 7, 1997. Correspondence

This article has been cited by other articles:

• Danesh, J., Pepys, M. B. (2009). C-Reactive Protein and Coronary Disease: Is There a Causal Link?. Circulation 120: 2036-2039 [Full Text]  
• Park, D.-W., Yun, S.-C., Lee, J.-Y., Kim, W.-J., Kang, S.-J., Lee, S.-W., Kim, Y.-H., Lee, C. W., Kim, J.-J., Park, S.-W., Park, S.-J. (2009). C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation. Circulation 120: 1987-1995 [Abstract] [Full Text]  
• Khawaja, F. J, Kullo, I. J (2009). Novel markers of peripheral arterial disease. Vasc Med 14: 381-392 [Abstract]  
• LIANG, K. P., MARADIT-KREMERS, H., CROWSON, C. S., SNYDER, M. R., THERNEAU, T. M., ROGER, V. L., GABRIEL, S. E. (2009). Autoantibodies and the Risk of Cardiovascular Events. The Journal of Rheumatology 36: 2462-2469 [Abstract] [Full Text]  
• Wright, C. B., Moon, Y., Paik, M. C., Brown, T. R., Rabbani, L., Yoshita, M., DeCarli, C., Sacco, R., Elkind, M. S.V. (2009). Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis. Stroke 40: 3466-3471 [Abstract] [Full Text]  
• Williams, S. R., Pham-Kanter, G., Leitsch, S. A. (2009). Measures of Chronic Conditions and Diseases Associated With Aging in the National Social Life, Health, and Aging Project. J Gerontol B Psychol Sci Soc Sci 64B: i67-i75 [Abstract] [Full Text]  
• Williams, S. R., McDade, T. W. (2009). The Use of Dried Blood Spot Sampling in the National Social Life, Health, and Aging Project. J Gerontol B Psychol Sci Soc Sci 64B: i131-i136 [Abstract] [Full Text]  
• Elkind, M.S.V., Luna, J. M., Moon, Y. P., Liu, K. M., Spitalnik, S. L., Paik, M. C., Sacco, R. L. (2009). High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study. Neurology 73: 1300-1307 [Abstract] [Full Text]  
• McNicholas, W. T. (2009). Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: Overlaps in Pathophysiology, Systemic Inflammation, and Cardiovascular Disease. Am. J. Respir. Crit. Care Med. 180: 692-700 [Abstract] [Full Text]  
• MacLaine, J. K., Rabie, A. B. M., Wong, R., Blechman, A. (2009). Does orthodontic tooth movement cause an elevation in systemic inflammatory markers?. Eur J Orthod 0: cjp108v1-cjp108 [Abstract] [Full Text]  
• Buckley, D. I., Fu, R., Freeman, M., Rogers, K., Helfand, M. (2009). C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force. ANN INTERN MED 151: 483-495 [Abstract] [Full Text]  
• Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., Humphrey, L. L. (2009). Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force. ANN INTERN MED 151: 496-507 [Abstract] [Full Text]  
• Frazier, L., Vaughn, W. K., Willerson, J. T., Ballantyne, C. M., Boerwinkle, E. (2009). Inflammatory Protein Levels and Depression Screening After Coronary Stenting Predict Major Adverse Coronary Events. Biol Res Nurs 11: 163-173 [Abstract]  
• Haubitz, M., Good, D. M., Woywodt, A., Haller, H., Rupprecht, H., Theodorescu, D., Dakna, M., Coon, J. J., Mischak, H. (2009). Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis. Mol. Cell. Proteomics 8: 2296-2307 [Abstract] [Full Text]  
• Conen, D., Rexrode, K. M., Creager, M. A., Ridker, P. M, Pradhan, A. D. (2009). Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women: A Prospective Study. Circulation 120: 1041-1047 [Abstract] [Full Text]  
• Pradhan, A. D., Everett, B. M., Cook, N. R., Rifai, N., Ridker, P. M (2009). Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial. JAMA 302: 1186-1194 [Abstract] [Full Text]  
• Swedberg, K. (2009). Fallacies in clinical cardiovascular trials. Heart 95: 1464-1468 [Full Text]  
• Ward, H., Mitrou, P. N., Bowman, R., Luben, R., Wareham, N. J., Khaw, K.-T., Bingham, S. (2009). APOE Genotype, Lipids, and Coronary Heart Disease Risk: A Prospective Population Study. Arch Intern Med 169: 1424-1429 [Abstract] [Full Text]  
• Procopio, C., Andreozzi, F., Laratta, E., Cassese, A., Beguinot, F., Arturi, F., Hribal, M. L., Perticone, F., Sesti, G. (2009). Leptin-Stimulated Endothelial Nitric-Oxide Synthase via an Adenosine 5'-Monophosphate-Activated Protein Kinase/Akt Signaling Pathway Is Attenuated by Interaction with C-Reactive Protein. Endocrinology 150: 3584-3593 [Abstract] [Full Text]  
• Eggers, K. M., Lagerqvist, B., Venge, P., Wallentin, L., Lindahl, B. (2009). Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.. J Am Coll Cardiol 54: 357-364 [Abstract] [Full Text]  
• Elliott, P., Chambers, J. C., Zhang, W., Clarke, R., Hopewell, J. C., Peden, J. F., Erdmann, J., Braund, P., Engert, J. C., Bennett, D., Coin, L., Ashby, D., Tzoulaki, I., Brown, I. J., Mt-Isa, S., McCarthy, M. I., Peltonen, L., Freimer, N. B., Farrall, M., Ruokonen, A., Hamsten, A., Lim, N., Froguel, P., Waterworth, D. M., Vollenweider, P., Waeber, G., Jarvelin, M.-R., Mooser, V., Scott, J., Hall, A. S., Schunkert, H., Anand, S. S., Collins, R., Samani, N. J., Watkins, H., Kooner, J. S. (2009). Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease. JAMA 302: 37-48 [Abstract] [Full Text]  
• Ryan, S, Taylor, C T, McNicholas, W T (2009). Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax 64: 631-636 [Abstract] [Full Text]  
• Abedini, S., Holme, I., Marz, W., Weihrauch, G., Fellstrom, B., Jardine, A., Cole, E., Maes, B., Neumayer, H.-H., Gronhagen-Riska, C., Ambuhl, P., Holdaas, H., on behalf of the ALERT study group, (2009). Inflammation in Renal Transplantation. CJASN 4: 1246-1254 [Abstract] [Full Text]  
• Rohleder, N., Marin, T. J., Ma, R., Miller, G. E. (2009). Biologic Cost of Caring for a Cancer Patient: Dysregulation of Pro- and Anti-Inflammatory Signaling Pathways. JCO 27: 2909-2915 [Abstract] [Full Text]  
• Agarwal, S. (2009). The Association of Active and Passive Smoking With Peripheral Arterial Disease: Results From NHANES 1999-2004. ANGIOLOGY 60: 335-345 [Abstract]  
• Ridker, P. M (2009). The JUPITER Trial: Results, Controversies, and Implications for Prevention. Circ Cardiovasc Qual Outcomes 2: 279-285 [Full Text]  
• Lavallee, P. C., Labreuche, J., Gongora-Rivera, F., Jaramillo, A., Brenner, D., Klein, I. F, Touboul, P.-J., Vicaut, E., Amarenco, P., on behalf of the Lacunar-B.I.C.H.A.T. Investigator, (2009). Placebo-Controlled Trial of High-Dose Atorvastatin in Patients With Severe Cerebral Small Vessel Disease. Stroke 40: 1721-1728 [Abstract] [Full Text]  
• Glynn, R. J., Danielson, E., Fonseca, F. A.H., Genest, J., Gotto, A. M. Jr., Kastelein, J. J.P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., Ridker, P. M (2009). A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism. NEJM 360: 1851-1861 [Abstract] [Full Text]  
• Lui, M. M.-s., Lam, J. C.-m., Mak, H. K.-F., Xu, A., Ooi, C., Lam, D. C.-l., Mak, J. C.-w., Khong, P. L., Ip, M. S.-M. (2009). C-Reactive Protein Is Associated With Obstructive Sleep Apnea Independent of Visceral Obesity. Chest 135: 950-956 [Abstract] [Full Text]  
• Karalis, D. G. (2009). Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease. Mayo Clin Proc. 84: 345-352 [Abstract] [Full Text]  
• Pabinger, I., Ay, C. (2009). Biomarkers and Venous Thromboembolism. Arterioscler. Thromb. Vasc. Bio. 29: 332-336 [Abstract] [Full Text]  
• SHAH, M. A., SHAH, A. M., KRISHNAN, E. (2009). Poor Outcomes After Acute Myocardial Infarction in Systemic Lupus Erythematosus. The Journal of Rheumatology 36: 570-575 [Abstract] [Full Text]  
• Chiriboga, D. E., Ma, Y., Li, W., Stanek, E. J. III, Hebert, J. R., Merriam, P. A., Rawson, E. S., Ockene, I. S. (2009). Seasonal and Sex Variation of High-Sensitivity C-Reactive Protein in Healthy Adults: A Longitudinal Study. Clin. Chem. 55: 313-321 [Abstract] [Full Text]  
• Biasucci, L. M., Liuzzo, G., Della Bona, R., Leo, M., Biasillo, G., Angiolillo, D. J., Abbate, A., Rizzello, V., Niccoli, G., Giubilato, S., Crea, F. (2009). Different Apparent Prognostic Value of hsCRP in Type 2 Diabetic and Nondiabetic Patients with Acute Coronary Syndromes. Clin. Chem. 55: 365-368 [Abstract] [Full Text]  
• Tracy, R. P. (2009). Simple and Reproducible ELISA for C-Reactive Protein. Clin. Chem. 55: 376-377 [Full Text]  
• Fujita, Y., Kakino, A., Nishimichi, N., Yamaguchi, S., Sato, Y., Machida, S., Cominacini, L., Delneste, Y., Matsuda, H., Sawamura, T. (2009). Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects. Clin. Chem. 55: 285-294 [Abstract] [Full Text]  
• Mora, S., Musunuru, K., Blumenthal, R. S. (2009). The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines. Clin. Chem. 55: 219-228 [Abstract] [Full Text]  
• Ruckerl, R., Peters, A., Khuseyinova, N., Andreani, M., Koenig, W., Meisinger, C., Dimakopoulou, K., Sunyer, J., Lanki, T., Nyberg, F., Schneider, A. (2009). Determinants of the Acute-Phase Protein C-Reactive Protein in Myocardial Infarction Survivors: The Role of Comorbidities and Environmental Factors. Clin. Chem. 55: 322-335 [Abstract] [Full Text]  
• Glynn, R. J., MacFadyen, J. G., Ridker, P. M (2009). Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study. Clin. Chem. 55: 305-312 [Abstract] [Full Text]  
• Ridker, P. M (2009). C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease. Clin. Chem. 55: 209-215 [Full Text]  
• Hingorani, A. D., Shah, T., Casas, J. P., Humphries, S. E., Talmud, P. J. (2009). C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?. Clin. Chem. 55: 239-255 [Abstract] [Full Text]  
• Schumacher, W., Cockcroft, J., Timpson, N. J., McEniery, C. M., Gallacher, J., Rumley, A., Lowe, G., Smith, G. D., Wilkinson, I. B., Ben-Shlomo, Y. (2009). Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity. Hypertension 53: 150-157 [Abstract] [Full Text]  
• Iijima, R, Byrne, R A, Ndrepepa, G, Braun, S, Mehilli, J, Berger, P B, Schomig, A, Kastrati, A (2009). Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart 95: 107-112 [Abstract] [Full Text]  
• SHISHEHBOR, M. H., HAZEN, S. L. (2009). JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?. Cleveland Clinic Journal of Medicine 76: 37-44 [Abstract] [Full Text]  
• Smith, D. T., Carr, L. J., Dorozynski, C., Gomashe, C. (2009). Internet-delivered lifestyle physical activity intervention: limited inflammation and antioxidant capacity efficacy in overweight adults. J. Appl. Physiol. 106: 49-56 [Abstract] [Full Text]  
• Montecucco, F., Mach, F. (2009). Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 48: 11-22 [Abstract] [Full Text]  
• Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F. (2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Frankel, D. S., Meigs, J. B., Massaro, J. M., Wilson, P. W.F., O'Donnell, C. J., D'Agostino, R. B., Tofler, G. H. (2008). Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease: The Framingham Offspring Study. Circulation 118: 2533-2539 [Abstract] [Full Text]  
• Galarraga, B., Khan, F., Kumar, P., Pullar, T., Belch, J. J. F. (2008). C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) 47: 1780-1784 [Abstract] [Full Text]  
• Ridker, P. M, Danielson, E., Fonseca, F. A.H., Genest, J., Gotto, A. M. Jr., Kastelein, J. J.P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., Glynn, R. J., the JUPITER Study Group, (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. NEJM 359: 2195-2207 [Abstract] [Full Text]  
• Eggers, K. M., Lind, L., Ahlstrom, H., Bjerner, T., Ebeling Barbier, C., Larsson, A., Venge, P., Lindahl, B. (2008). Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 29: 2252-2258 [Abstract] [Full Text]  
• Steinberg, D., Eichhorn, E. J., Connor, W. E., Diamond, G. A., Kaul, S., Blake, J. A., Davis, H. R. Jr., Murgolo, N. J., Graziano, M. P., Kaye, T., Akdim, F., de Groot, E., Kastelein, J. J.P., Brown, B. G. (2008). Simvastatin with or without ezetimibe in familial hypercholesterolemia.. NEJM 359: 529-530 [Full Text]  
• Moat, S. J (2008). Plasma total homocysteine: instigator or indicator of cardiovascular disease?. Ann Clin Biochem 45: 345-348 [Abstract] [Full Text]  
• Koizumi, Y., Kurita-Ochiai, T., Oguchi, S., Yamamoto, M. (2008). Nasal Immunization with Porphyromonas gingivalis Outer Membrane Protein Decreases P. gingivalis-Induced Atherosclerosis and Inflammation in Spontaneously Hyperlipidemic Mice. Infect. Immun. 76: 2958-2965 [Abstract] [Full Text]  
• Utz, A. L., Yamamoto, A., Hemphill, L., Miller, K. K. (2008). Growth Hormone Deficiency by Growth Hormone Releasing Hormone-Arginine Testing Criteria Predicts Increased Cardiovascular Risk Markers in Normal Young Overweight and Obese Women. J. Clin. Endocrinol. Metab. 93: 2507-2514 [Abstract] [Full Text]  
• Arima, H., Kubo, M., Yonemoto, K., Doi, Y., Ninomiya, T., Tanizaki, Y., Hata, J., Matsumura, K., Iida, M., Kiyohara, Y. (2008). High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese: The Hisayama Study. Arterioscler. Thromb. Vasc. Bio. 28: 1385-1391 [Abstract] [Full Text]  
• Tousoulis, D, Charakida, M, Stefanadis, C (2008). Endothelial function and inflammation in coronary artery disease. Postgrad. Med. J. 84: 368-371 [Abstract] [Full Text]  
• Pai, A. B., Conner, T. A. (2008). Oxidative Stress and Inflammation in Chronic Kidney Disease: Role of Intravenous Iron and Vitamin D. Journal of Pharmacy Practice 21: 214-224 [Abstract]  
• Kelley-Hedgepeth, A., Lloyd-Jones, D. M., Colvin, A., Matthews, K. A., Johnston, J., Sowers, M. R., Sternfeld, B., Pasternak, R. C., Chae, C. U., for the SWAN Investigators, (2008). Ethnic Differences in C-Reactive Protein Concentrations. Clin. Chem. 54: 1027-1037 [Abstract] [Full Text]  
• Patrono, C., Baigent, C., Hirsh, J., Roth, G. (2008). Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 199S-233S [Abstract] [Full Text]  
• Gasparyan, A. Y., Watson, T., Lip, G. Y.H. (2008). The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance. J Am Coll Cardiol 51: 1829-1843 [Abstract] [Full Text]  
• Ortolani, P., Marzocchi, A., Marrozzini, C., Palmerini, T., Saia, F., Taglieri, N., Baldazzi, F., Silenzi, S., Bacchi-Reggiani, M. L., Guastaroba, P., Grilli, R., Branzi, A. (2008). Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. Eur Heart J 29: 1241-1249 [Abstract] [Full Text]  
• Malarstig, A., Eriksson, P., Rose, L., Diehl, K. A., Hamsten, A., Ridker, P. M, Zee, R. Y.L. (2008). Genetic Variants of Tumor Necrosis Factor Superfamily, Member 4 (TNFSF4), and Risk of Incident Atherothrombosis and Venous Thromboembolism. Clin. Chem. 54: 833-840 [Abstract] [Full Text]  
• Wung, S.-F., Aouizerat, B. E. (2008). Candidate Genes of the 5-Lipoxygenase Pathway in Acute Coronary Syndrome: A Pilot Study. Biol Res Nurs 9: 280-292 [Abstract]  
• Danese, A., Moffitt, T. E., Pariante, C. M., Ambler, A., Poulton, R., Caspi, A. (2008). Elevated Inflammation Levels in Depressed Adults With a History of Childhood Maltreatment. Arch Gen Psychiatry 65: 409-415 [Abstract] [Full Text]  
• Anuurad, E., Rubin, J., Chiem, A., Tracy, R. P., Pearson, T. A., Berglund, L. (2008). High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans. J. Clin. Endocrinol. Metab. 93: 1482-1488 [Abstract] [Full Text]  
• Clarke, R., Emberson, J. R., Breeze, E., Casas, J. P., Parish, S., Hingorani, A. D., Fletcher, A., Collins, R., Smeeth, L. (2008). Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 29: 800-809 [Abstract] [Full Text]  
• Hennekens, C. H., Borzak, S. (2008). Cyclooxygenase-2 Inhibitors and Most Traditional Nonsteroidal Anti-inflammatory Drugs Cause Similar Moderately Increased Risks of Cardiovascular Disease. J CARDIOVASC PHARMACOL THER 13: 41-50 [Abstract]  
• Conen, D, Everett, B M, Glynn, R J, Ridker, P M (2008). Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart 94: e13-e13 [Abstract] [Full Text]  
• Lee, S-S., Singh, S., Magder, L., Petri, M. (2008). Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 17: 114-123 [Abstract]  
• Marsik, C., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., Endler, G. (2008). C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort. Clin. Chem. 54: 343-349 [Abstract] [Full Text]  
• Higashi, Y., Goto, C., Jitsuiki, D., Umemura, T., Nishioka, K., Hidaka, T., Takemoto, H., Nakamura, S., Soga, J., Chayama, K., Yoshizumi, M., Taguchi, A. (2008). Periodontal Infection Is Associated With Endothelial Dysfunction in Healthy Subjects and Hypertensive Patients. Hypertension 51: 446-453 [Abstract] [Full Text]  
• Ulucay, A., Demirbag, R., Yilmaz, R., Unlu, D., Gur, M., Selek, S., Celik, H. (2008). The Relationship Between Plasma C-Reactive Protein Levels and Presence and Severity of Coronary Stenosis in Patients With Stable Angina. ANGIOLOGY 58: 657-662 [Abstract]  
• Saglam, M., Karakaya, O., Barutcu, I., Esen, A. M., Turkmen, M., Kargin, R., Esen, O., Ozdemir, N., Kaymaz, C. (2008). Identifying Cardiovascular Risk Factors in a Patient Population With Coronary Artery Ectasia. ANGIOLOGY 58: 698-703 [Abstract]  
• Packard, R. R. S., Libby, P. (2008). Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clin. Chem. 54: 24-38 [Abstract] [Full Text]  
• Kinlay, S., Schwartz, G. G., Olsson, A. G., Rifai, N., Szarek, M., Waters, D. D., Libby, P., Ganz, P., for the Myocardial Ischemia Reduction with Aggress, (2008). Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study. Arterioscler. Thromb. Vasc. Bio. 28: 142-147 [Abstract] [Full Text]  
• Deeb, R. S., Upmacis, R. K., Lamon, B. D., Gross, S. S., Hajjar, D. P. (2008). Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways: Promising Offensives Against Vascular Injury. Hypertension 51: 1-7 [Full Text]  
• Otter, W., Winter, M., Doering, W., Standl, E., Schnell, O. (2007). C-Reactive Protein in Diabetic and Nondiabetic Patients With Acute Myocardial Infarction. Diabetes Care 30: 3080-3082 [Full Text]  
• Hamburg, N. M., McMackin, C. J., Huang, A. L., Shenouda, S. M., Widlansky, M. E., Schulz, E., Gokce, N., Ruderman, N. B., Keaney, J. F. Jr, Vita, J. A. (2007). Physical Inactivity Rapidly Induces Insulin Resistance and Microvascular Dysfunction in Healthy Volunteers. Arterioscler. Thromb. Vasc. Bio. 27: 2650-2656 [Abstract] [Full Text]  
• Issac, T. T., Dokainish, H., Lakkis, N. M. (2007). Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data. J Am Coll Cardiol 50: 2021-2028 [Abstract] [Full Text]  
• O'Rourke, M. F. (2007). Arterial aging: pathophysiological principles. Vasc Med 12: 329-341 [Abstract]  
• Mullenix, P. S., Steele, S. R., Martin, M. J., Starnes, B. W., Andersen, C. A. (2007). C-reactive Protein Level and Traditional Vascular Risk Factors in the Prediction of Carotid Stenosis. Arch Surg 142: 1066-1071 [Abstract] [Full Text]  
• Spagnoli, L. G., Bonanno, E., Sangiorgi, G., Mauriello, A. (2007). Role of Inflammation in Atherosclerosis. JNM 48: 1800-1815 [Abstract] [Full Text]  
• Sander, K., Schulze Horn, C., Briesenick, C., Sander, D. (2007). High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study. Stroke 38: 2881-2886 [Abstract] [Full Text]  
• Gortney, J. S., Sanders, R. M. (2007). Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health Syst Pharm 64: 2009-2016 [Abstract] [Full Text]  
• Edwards, C J, Syddall, H, Goswami, R, Goswami, P, Dennison, E M, Arden, N K, Cooper, C, on behalf of the Hertfordshire Cohort Study Group, (2007). The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 93: 1263-1267 [Abstract] [Full Text]  
• Patel, D. N., King, C. A., Bailey, S. R., Holt, J. W., Venkatachalam, K., Agrawal, A., Valente, A. J., Chandrasekar, B. (2007). Interleukin-17 Stimulates C-reactive Protein Expression in Hepatocytes and Smooth Muscle Cells via p38 MAPK and ERK1/2-dependent NF-{kappa}B and C/EBPbeta Activation. J. Biol. Chem. 282: 27229-27238 [Abstract] [Full Text]